CytoSorbents Corporation (HQE1)
XSTU
5.92
0.00 (0.00%)
Real-time Data
06:00 AM
Day's Range
5.925.92
52 wk Range
0.29805.92
Financial Statements - HQE1 - CytoSorbents Corporation
Revenue
37.06M▲ 4.1%
Net Income
-8.19M▲ 60.4%Net Margin -22.1%
EBITDA
-13.16M▲ 12.5%
Free Cash Flow
-12.86M▲ 14.8%
Income Statement
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|---|---|
| Sales | 37.06M | 35.59M | 31.08M | 29.35M | 40.10M | 39.45M |
| Cost of Goods | 10.57M | 10.46M | 13.95M | 13.95M | 11.04M | 11.05M |
| Gross Profit | 26.49M | 25.12M | 17.12M | 15.40M | 29.06M | 28.40M |
 Operating Expense | - | - | - | - | - | - |
| Operating Income | -14.23M | -16.78M | -31.20M | -31.52M | -22.74M | -10.37M |
| Non-Operating Interest | - | - | - | - | - | - |
| Other Income Expense | 8.25M | -4.22M | 2.04M | -2.51M | -2.57M | 2.60M |
| Pre Tax Income | -8.59M | -22.40M | -29.32M | -33.90M | -25.29M | -8.96M |
| Income Tax | -401K | -1.69M | -813.73K | -1.09M | -736K | -1.12M |
| Net Income | -8.19M | -20.71M | -28.50M | -32.81M | -24.55M | -7.83M |
| EPS Basic | -2.6 | -0.38 | -0.64 | -0.75 | -0.57 | -0.2 |
| EPS Diluted | -2.6 | -0.38 | -0.64 | -0.75 | -0.57 | -0.2 |
| Basic Shares Outstanding | 3.11M | 54.43M | 48.61M | 45.34M | 45.12M | 40.39M |
| Diluted Shares Outstanding | 3.11M | 54.43M | 48.61M | 45.34M | 45.12M | 40.39M |
| Ebit | -5.98M | -21.01M | -31.20M | -31.52M | -22.74M | -10.37M |
| Ebitda | -13.16M | -15.04M | -31.13M | -27.94M | -19.03M | -12.31M |
| Net Income Continuous Operations | -8.19M | -20.71M | -28.50M | -32.81M | -24.55M | -7.83M |
| Minority Interests | - | - | - | - | - | - |
| Preferred Stock Dividends | - | - | - | - | - | - |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
